Global Complement Drug Production, Demand and Key Producers, 2022-2028
This report studies the global Complement Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Complement Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Complement Drug that contribute to its increasing demand across many markets.
The global Complement Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Complement Drug total market, 2017-2028, (USD Million)
Global Complement Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Complement Drug total market, key domestic companies and share, (USD Million)
Global Complement Drug revenue by player and market share 2017-2022, (USD Million)
Global Complement Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global Complement Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Complement Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam and UCB, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Complement Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Complement Drug Market, By Region:
1. How big is the global Complement Drug market?
2. What is the demand of the global Complement Drug market?
3. What is the year over year growth of the global Complement Drug market?
4. What is the total value of the global Complement Drug market?
5. Who are the major players in the global Complement Drug market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Complement Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Complement Drug that contribute to its increasing demand across many markets.
The global Complement Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Complement Drug total market, 2017-2028, (USD Million)
Global Complement Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Complement Drug total market, key domestic companies and share, (USD Million)
Global Complement Drug revenue by player and market share 2017-2022, (USD Million)
Global Complement Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global Complement Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Complement Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam and UCB, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Complement Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Complement Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Peptides
- Antibodies
- Others
- Blood Disease
- Kidney Disease
- Others
- Novartis AG
- Alexion Pharmaceuticals
- ChemoCentryx
- Roche
- Apellis
- Regeneron
- Amgen
- Alnylam
- UCB
- InflaRx
- ChemoCentryx
- Innate Pharma
- Ionis Pharmaceuticals
- Avant Immunotherapeutics
- Pfizer
- Sanofi
- Omeros
- GenMab
- Akari Therapeutics
- AbbVie
1. How big is the global Complement Drug market?
2. What is the demand of the global Complement Drug market?
3. What is the year over year growth of the global Complement Drug market?
4. What is the total value of the global Complement Drug market?
5. Who are the major players in the global Complement Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Complement Drug Introduction
1.2 World Complement Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Complement Drug Total Market by Region
1.3.1 World Complement Drug Market Size by Region (2017-2028)
1.3.2 United States Complement Drug Market Size (2017-2028)
1.3.3 China Complement Drug Market Size (2017-2028)
1.3.4 Europe Complement Drug Market Size (2017-2028)
1.3.5 Japan Complement Drug Market Size (2017-2028)
1.3.6 South Korea Complement Drug Market Size (2017-2028)
1.3.7 ASEAN Complement Drug Market Size (2017-2028)
1.3.8 India Complement Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Complement Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Complement Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD COMPLEMENT DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World Complement Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Complement Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Complement Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for Complement Drug in 2021
2.3 Complement Drug Company Evaluation Quadrant
2.4 Complement Drug Market: Overall Company Footprint Analysis
2.4.1 Complement Drug Market: Region Footprint
2.4.2 Complement Drug Market: Company Product Type Footprint
2.4.3 Complement Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Complement Drug Market Comparison
3.1.1 United States VS China: Complement Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Complement Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Complement Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of Complement Drug in United States, Headquarters (States, Country)
3.2.2 United States Complement Drug Revenue by Domestic Player, (2017-2022)
3.3 China Complement Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of Complement Drug in China, Headquarters (Province, Country)
3.3.2 China Complement Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Complement Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of Complement Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Complement Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Complement Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Peptides
4.2.2 Antibodies
4.2.3 Others
4.3 Market Segment by Type
4.3.1 World Complement Drug Market Size by Type (2017-2022)
4.3.2 World Complement Drug Market Size by Type (2023-2028)
4.3.3 World Complement Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Complement Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Blood Disease
5.2.2 Kidney Disease
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Complement Drug Market Size by Application (2017-2022)
5.3.2 World Complement Drug Market Size by Application (2023-2028)
5.3.3 World Complement Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Novartis AG
6.1.1 Novartis AG Details
6.1.2 Novartis AG Major Business
6.1.3 Novartis AG Complement Drug Product and Services
6.1.4 Novartis AG Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Novartis AG Recent Developments/Updates
6.1.6 Novartis AG Competitive Strengths & Weaknesses
6.2 Alexion Pharmaceuticals
6.2.1 Alexion Pharmaceuticals Details
6.2.2 Alexion Pharmaceuticals Major Business
6.2.3 Alexion Pharmaceuticals Complement Drug Product and Services
6.2.4 Alexion Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Alexion Pharmaceuticals Recent Developments/Updates
6.2.6 Alexion Pharmaceuticals Competitive Strengths & Weaknesses
6.3 ChemoCentryx
6.3.1 ChemoCentryx Details
6.3.2 ChemoCentryx Major Business
6.3.3 ChemoCentryx Complement Drug Product and Services
6.3.4 ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 ChemoCentryx Recent Developments/Updates
6.3.6 ChemoCentryx Competitive Strengths & Weaknesses
6.4 Roche
6.4.1 Roche Details
6.4.2 Roche Major Business
6.4.3 Roche Complement Drug Product and Services
6.4.4 Roche Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Roche Recent Developments/Updates
6.4.6 Roche Competitive Strengths & Weaknesses
6.5 Apellis
6.5.1 Apellis Details
6.5.2 Apellis Major Business
6.5.3 Apellis Complement Drug Product and Services
6.5.4 Apellis Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Apellis Recent Developments/Updates
6.5.6 Apellis Competitive Strengths & Weaknesses
6.6 Regeneron
6.6.1 Regeneron Details
6.6.2 Regeneron Major Business
6.6.3 Regeneron Complement Drug Product and Services
6.6.4 Regeneron Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Regeneron Recent Developments/Updates
6.6.6 Regeneron Competitive Strengths & Weaknesses
6.7 Amgen
6.7.1 Amgen Details
6.7.2 Amgen Major Business
6.7.3 Amgen Complement Drug Product and Services
6.7.4 Amgen Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Amgen Recent Developments/Updates
6.7.6 Amgen Competitive Strengths & Weaknesses
6.8 Alnylam
6.8.1 Alnylam Details
6.8.2 Alnylam Major Business
6.8.3 Alnylam Complement Drug Product and Services
6.8.4 Alnylam Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Alnylam Recent Developments/Updates
6.8.6 Alnylam Competitive Strengths & Weaknesses
6.9 UCB
6.9.1 UCB Details
6.9.2 UCB Major Business
6.9.3 UCB Complement Drug Product and Services
6.9.4 UCB Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 UCB Recent Developments/Updates
6.9.6 UCB Competitive Strengths & Weaknesses
6.10 InflaRx
6.10.1 InflaRx Details
6.10.2 InflaRx Major Business
6.10.3 InflaRx Complement Drug Product and Services
6.10.4 InflaRx Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 InflaRx Recent Developments/Updates
6.10.6 InflaRx Competitive Strengths & Weaknesses
6.11 ChemoCentryx
6.11.1 ChemoCentryx Details
6.11.2 ChemoCentryx Major Business
6.11.3 ChemoCentryx Complement Drug Product and Services
6.11.4 ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 ChemoCentryx Recent Developments/Updates
6.11.6 ChemoCentryx Competitive Strengths & Weaknesses
6.12 Innate Pharma
6.12.1 Innate Pharma Details
6.12.2 Innate Pharma Major Business
6.12.3 Innate Pharma Complement Drug Product and Services
6.12.4 Innate Pharma Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Innate Pharma Recent Developments/Updates
6.12.6 Innate Pharma Competitive Strengths & Weaknesses
6.13 Ionis Pharmaceuticals
6.13.1 Ionis Pharmaceuticals Details
6.13.2 Ionis Pharmaceuticals Major Business
6.13.3 Ionis Pharmaceuticals Complement Drug Product and Services
6.13.4 Ionis Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Ionis Pharmaceuticals Recent Developments/Updates
6.13.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
6.14 Avant Immunotherapeutics
6.14.1 Avant Immunotherapeutics Details
6.14.2 Avant Immunotherapeutics Major Business
6.14.3 Avant Immunotherapeutics Complement Drug Product and Services
6.14.4 Avant Immunotherapeutics Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Avant Immunotherapeutics Recent Developments/Updates
6.14.6 Avant Immunotherapeutics Competitive Strengths & Weaknesses
6.15 Pfizer
6.15.1 Pfizer Details
6.15.2 Pfizer Major Business
6.15.3 Pfizer Complement Drug Product and Services
6.15.4 Pfizer Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Pfizer Recent Developments/Updates
6.15.6 Pfizer Competitive Strengths & Weaknesses
6.16 Sanofi
6.16.1 Sanofi Details
6.16.2 Sanofi Major Business
6.16.3 Sanofi Complement Drug Product and Services
6.16.4 Sanofi Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Sanofi Recent Developments/Updates
6.16.6 Sanofi Competitive Strengths & Weaknesses
6.17 Omeros
6.17.1 Omeros Details
6.17.2 Omeros Major Business
6.17.3 Omeros Complement Drug Product and Services
6.17.4 Omeros Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Omeros Recent Developments/Updates
6.17.6 Omeros Competitive Strengths & Weaknesses
6.18 GenMab
6.18.1 GenMab Details
6.18.2 GenMab Major Business
6.18.3 GenMab Complement Drug Product and Services
6.18.4 GenMab Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 GenMab Recent Developments/Updates
6.18.6 GenMab Competitive Strengths & Weaknesses
6.19 Akari Therapeutics
6.19.1 Akari Therapeutics Details
6.19.2 Akari Therapeutics Major Business
6.19.3 Akari Therapeutics Complement Drug Product and Services
6.19.4 Akari Therapeutics Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Akari Therapeutics Recent Developments/Updates
6.19.6 Akari Therapeutics Competitive Strengths & Weaknesses
6.20 AbbVie
6.20.1 AbbVie Details
6.20.2 AbbVie Major Business
6.20.3 AbbVie Complement Drug Product and Services
6.20.4 AbbVie Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 AbbVie Recent Developments/Updates
6.20.6 AbbVie Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Complement Drug and Key Manufacturers
7.2 Complement Drug Manufacturing Costs
7.3 Complement Drug Production Process
7.4 Complement Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Complement Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Complement Drug Typical Distributors
8.3 Complement Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Complement Drug Introduction
1.2 World Complement Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Complement Drug Total Market by Region
1.3.1 World Complement Drug Market Size by Region (2017-2028)
1.3.2 United States Complement Drug Market Size (2017-2028)
1.3.3 China Complement Drug Market Size (2017-2028)
1.3.4 Europe Complement Drug Market Size (2017-2028)
1.3.5 Japan Complement Drug Market Size (2017-2028)
1.3.6 South Korea Complement Drug Market Size (2017-2028)
1.3.7 ASEAN Complement Drug Market Size (2017-2028)
1.3.8 India Complement Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Complement Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Complement Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD COMPLEMENT DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World Complement Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Complement Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Complement Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for Complement Drug in 2021
2.3 Complement Drug Company Evaluation Quadrant
2.4 Complement Drug Market: Overall Company Footprint Analysis
2.4.1 Complement Drug Market: Region Footprint
2.4.2 Complement Drug Market: Company Product Type Footprint
2.4.3 Complement Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Complement Drug Market Comparison
3.1.1 United States VS China: Complement Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Complement Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Complement Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of Complement Drug in United States, Headquarters (States, Country)
3.2.2 United States Complement Drug Revenue by Domestic Player, (2017-2022)
3.3 China Complement Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of Complement Drug in China, Headquarters (Province, Country)
3.3.2 China Complement Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Complement Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of Complement Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Complement Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Complement Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Peptides
4.2.2 Antibodies
4.2.3 Others
4.3 Market Segment by Type
4.3.1 World Complement Drug Market Size by Type (2017-2022)
4.3.2 World Complement Drug Market Size by Type (2023-2028)
4.3.3 World Complement Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Complement Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Blood Disease
5.2.2 Kidney Disease
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Complement Drug Market Size by Application (2017-2022)
5.3.2 World Complement Drug Market Size by Application (2023-2028)
5.3.3 World Complement Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Novartis AG
6.1.1 Novartis AG Details
6.1.2 Novartis AG Major Business
6.1.3 Novartis AG Complement Drug Product and Services
6.1.4 Novartis AG Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Novartis AG Recent Developments/Updates
6.1.6 Novartis AG Competitive Strengths & Weaknesses
6.2 Alexion Pharmaceuticals
6.2.1 Alexion Pharmaceuticals Details
6.2.2 Alexion Pharmaceuticals Major Business
6.2.3 Alexion Pharmaceuticals Complement Drug Product and Services
6.2.4 Alexion Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Alexion Pharmaceuticals Recent Developments/Updates
6.2.6 Alexion Pharmaceuticals Competitive Strengths & Weaknesses
6.3 ChemoCentryx
6.3.1 ChemoCentryx Details
6.3.2 ChemoCentryx Major Business
6.3.3 ChemoCentryx Complement Drug Product and Services
6.3.4 ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 ChemoCentryx Recent Developments/Updates
6.3.6 ChemoCentryx Competitive Strengths & Weaknesses
6.4 Roche
6.4.1 Roche Details
6.4.2 Roche Major Business
6.4.3 Roche Complement Drug Product and Services
6.4.4 Roche Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Roche Recent Developments/Updates
6.4.6 Roche Competitive Strengths & Weaknesses
6.5 Apellis
6.5.1 Apellis Details
6.5.2 Apellis Major Business
6.5.3 Apellis Complement Drug Product and Services
6.5.4 Apellis Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Apellis Recent Developments/Updates
6.5.6 Apellis Competitive Strengths & Weaknesses
6.6 Regeneron
6.6.1 Regeneron Details
6.6.2 Regeneron Major Business
6.6.3 Regeneron Complement Drug Product and Services
6.6.4 Regeneron Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Regeneron Recent Developments/Updates
6.6.6 Regeneron Competitive Strengths & Weaknesses
6.7 Amgen
6.7.1 Amgen Details
6.7.2 Amgen Major Business
6.7.3 Amgen Complement Drug Product and Services
6.7.4 Amgen Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Amgen Recent Developments/Updates
6.7.6 Amgen Competitive Strengths & Weaknesses
6.8 Alnylam
6.8.1 Alnylam Details
6.8.2 Alnylam Major Business
6.8.3 Alnylam Complement Drug Product and Services
6.8.4 Alnylam Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Alnylam Recent Developments/Updates
6.8.6 Alnylam Competitive Strengths & Weaknesses
6.9 UCB
6.9.1 UCB Details
6.9.2 UCB Major Business
6.9.3 UCB Complement Drug Product and Services
6.9.4 UCB Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 UCB Recent Developments/Updates
6.9.6 UCB Competitive Strengths & Weaknesses
6.10 InflaRx
6.10.1 InflaRx Details
6.10.2 InflaRx Major Business
6.10.3 InflaRx Complement Drug Product and Services
6.10.4 InflaRx Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 InflaRx Recent Developments/Updates
6.10.6 InflaRx Competitive Strengths & Weaknesses
6.11 ChemoCentryx
6.11.1 ChemoCentryx Details
6.11.2 ChemoCentryx Major Business
6.11.3 ChemoCentryx Complement Drug Product and Services
6.11.4 ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 ChemoCentryx Recent Developments/Updates
6.11.6 ChemoCentryx Competitive Strengths & Weaknesses
6.12 Innate Pharma
6.12.1 Innate Pharma Details
6.12.2 Innate Pharma Major Business
6.12.3 Innate Pharma Complement Drug Product and Services
6.12.4 Innate Pharma Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Innate Pharma Recent Developments/Updates
6.12.6 Innate Pharma Competitive Strengths & Weaknesses
6.13 Ionis Pharmaceuticals
6.13.1 Ionis Pharmaceuticals Details
6.13.2 Ionis Pharmaceuticals Major Business
6.13.3 Ionis Pharmaceuticals Complement Drug Product and Services
6.13.4 Ionis Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Ionis Pharmaceuticals Recent Developments/Updates
6.13.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
6.14 Avant Immunotherapeutics
6.14.1 Avant Immunotherapeutics Details
6.14.2 Avant Immunotherapeutics Major Business
6.14.3 Avant Immunotherapeutics Complement Drug Product and Services
6.14.4 Avant Immunotherapeutics Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Avant Immunotherapeutics Recent Developments/Updates
6.14.6 Avant Immunotherapeutics Competitive Strengths & Weaknesses
6.15 Pfizer
6.15.1 Pfizer Details
6.15.2 Pfizer Major Business
6.15.3 Pfizer Complement Drug Product and Services
6.15.4 Pfizer Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Pfizer Recent Developments/Updates
6.15.6 Pfizer Competitive Strengths & Weaknesses
6.16 Sanofi
6.16.1 Sanofi Details
6.16.2 Sanofi Major Business
6.16.3 Sanofi Complement Drug Product and Services
6.16.4 Sanofi Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Sanofi Recent Developments/Updates
6.16.6 Sanofi Competitive Strengths & Weaknesses
6.17 Omeros
6.17.1 Omeros Details
6.17.2 Omeros Major Business
6.17.3 Omeros Complement Drug Product and Services
6.17.4 Omeros Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Omeros Recent Developments/Updates
6.17.6 Omeros Competitive Strengths & Weaknesses
6.18 GenMab
6.18.1 GenMab Details
6.18.2 GenMab Major Business
6.18.3 GenMab Complement Drug Product and Services
6.18.4 GenMab Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 GenMab Recent Developments/Updates
6.18.6 GenMab Competitive Strengths & Weaknesses
6.19 Akari Therapeutics
6.19.1 Akari Therapeutics Details
6.19.2 Akari Therapeutics Major Business
6.19.3 Akari Therapeutics Complement Drug Product and Services
6.19.4 Akari Therapeutics Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Akari Therapeutics Recent Developments/Updates
6.19.6 Akari Therapeutics Competitive Strengths & Weaknesses
6.20 AbbVie
6.20.1 AbbVie Details
6.20.2 AbbVie Major Business
6.20.3 AbbVie Complement Drug Product and Services
6.20.4 AbbVie Complement Drug Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 AbbVie Recent Developments/Updates
6.20.6 AbbVie Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Complement Drug and Key Manufacturers
7.2 Complement Drug Manufacturing Costs
7.3 Complement Drug Production Process
7.4 Complement Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Complement Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Complement Drug Typical Distributors
8.3 Complement Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Complement Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Complement Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World Complement Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World Complement Drug Market Size Market Share by Region (2017-2022)
Table 5. World Complement Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Complement Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Complement Drug Players in 2021
Table 9. World Complement Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Complement Drug Company Evaluation Quadrant
Table 11. Head Office of Key Complement Drug Player
Table 12. Complement Drug Market: Company Product Type Footprint
Table 13. Complement Drug Market: Company Product Application Footprint
Table 14. Complement Drug Mergers & Acquisitions Activity
Table 15. United States VS China Complement Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Complement Drug in United States, Headquarters (States, Country)
Table 17. United States Complement Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Complement Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Complement Drug in China, Company Headquarters (Province, Country)
Table 20. China Complement Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Complement Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Complement Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Complement Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Complement Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Complement Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Complement Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World Complement Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World Complement Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Complement Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World Complement Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 32. Novartis AG Major Business
Table 33. Novartis AG Complement Drug Product and Services
Table 34. Novartis AG Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Novartis AG Recent Developments/Updates
Table 36. Novartis AG Competitive Strengths & Weaknesses
Table 37. Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. Alexion Pharmaceuticals Major Business
Table 39. Alexion Pharmaceuticals Complement Drug Product and Services
Table 40. Alexion Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Alexion Pharmaceuticals Recent Developments/Updates
Table 42. Alexion Pharmaceuticals Competitive Strengths & Weaknesses
Table 43. ChemoCentryx Basic Information, Manufacturing Base and Competitors
Table 44. ChemoCentryx Major Business
Table 45. ChemoCentryx Complement Drug Product and Services
Table 46. ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. ChemoCentryx Recent Developments/Updates
Table 48. ChemoCentryx Competitive Strengths & Weaknesses
Table 49. Roche Basic Information, Manufacturing Base and Competitors
Table 50. Roche Major Business
Table 51. Roche Complement Drug Product and Services
Table 52. Roche Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Roche Recent Developments/Updates
Table 54. Roche Competitive Strengths & Weaknesses
Table 55. Apellis Basic Information, Manufacturing Base and Competitors
Table 56. Apellis Major Business
Table 57. Apellis Complement Drug Product and Services
Table 58. Apellis Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Apellis Recent Developments/Updates
Table 60. Apellis Competitive Strengths & Weaknesses
Table 61. Regeneron Basic Information, Manufacturing Base and Competitors
Table 62. Regeneron Major Business
Table 63. Regeneron Complement Drug Product and Services
Table 64. Regeneron Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Regeneron Recent Developments/Updates
Table 66. Regeneron Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Complement Drug Product and Services
Table 70. Amgen Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Alnylam Basic Information, Manufacturing Base and Competitors
Table 74. Alnylam Major Business
Table 75. Alnylam Complement Drug Product and Services
Table 76. Alnylam Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Alnylam Recent Developments/Updates
Table 78. Alnylam Competitive Strengths & Weaknesses
Table 79. UCB Basic Information, Manufacturing Base and Competitors
Table 80. UCB Major Business
Table 81. UCB Complement Drug Product and Services
Table 82. UCB Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. UCB Recent Developments/Updates
Table 84. UCB Competitive Strengths & Weaknesses
Table 85. InflaRx Basic Information, Manufacturing Base and Competitors
Table 86. InflaRx Major Business
Table 87. InflaRx Complement Drug Product and Services
Table 88. InflaRx Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. InflaRx Recent Developments/Updates
Table 90. InflaRx Competitive Strengths & Weaknesses
Table 91. ChemoCentryx Basic Information, Manufacturing Base and Competitors
Table 92. ChemoCentryx Major Business
Table 93. ChemoCentryx Complement Drug Product and Services
Table 94. ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. ChemoCentryx Recent Developments/Updates
Table 96. ChemoCentryx Competitive Strengths & Weaknesses
Table 97. Innate Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Innate Pharma Major Business
Table 99. Innate Pharma Complement Drug Product and Services
Table 100. Innate Pharma Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Innate Pharma Recent Developments/Updates
Table 102. Innate Pharma Competitive Strengths & Weaknesses
Table 103. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Ionis Pharmaceuticals Major Business
Table 105. Ionis Pharmaceuticals Complement Drug Product and Services
Table 106. Ionis Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Ionis Pharmaceuticals Recent Developments/Updates
Table 108. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Avant Immunotherapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Avant Immunotherapeutics Major Business
Table 111. Avant Immunotherapeutics Complement Drug Product and Services
Table 112. Avant Immunotherapeutics Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Avant Immunotherapeutics Recent Developments/Updates
Table 114. Avant Immunotherapeutics Competitive Strengths & Weaknesses
Table 115. Pfizer Basic Information, Manufacturing Base and Competitors
Table 116. Pfizer Major Business
Table 117. Pfizer Complement Drug Product and Services
Table 118. Pfizer Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Pfizer Recent Developments/Updates
Table 120. Pfizer Competitive Strengths & Weaknesses
Table 121. Sanofi Basic Information, Manufacturing Base and Competitors
Table 122. Sanofi Major Business
Table 123. Sanofi Complement Drug Product and Services
Table 124. Sanofi Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Sanofi Recent Developments/Updates
Table 126. Sanofi Competitive Strengths & Weaknesses
Table 127. Omeros Basic Information, Manufacturing Base and Competitors
Table 128. Omeros Major Business
Table 129. Omeros Complement Drug Product and Services
Table 130. Omeros Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Omeros Recent Developments/Updates
Table 132. Omeros Competitive Strengths & Weaknesses
Table 133. GenMab Basic Information, Manufacturing Base and Competitors
Table 134. GenMab Major Business
Table 135. GenMab Complement Drug Product and Services
Table 136. GenMab Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. GenMab Recent Developments/Updates
Table 138. GenMab Competitive Strengths & Weaknesses
Table 139. Akari Therapeutics Basic Information, Manufacturing Base and Competitors
Table 140. Akari Therapeutics Major Business
Table 141. Akari Therapeutics Complement Drug Product and Services
Table 142. Akari Therapeutics Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Akari Therapeutics Recent Developments/Updates
Table 144. AbbVie Basic Information, Manufacturing Base and Competitors
Table 145. AbbVie Major Business
Table 146. AbbVie Complement Drug Product and Services
Table 147. AbbVie Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 148. Complement Drug Raw Material
Table 149. Key Manufacturers of Complement Drug Raw Materials
Table 150. Complement Drug Typical Distributors
Table 151. Complement Drug Typical Customers
Table 1. World Complement Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Complement Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World Complement Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World Complement Drug Market Size Market Share by Region (2017-2022)
Table 5. World Complement Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Complement Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Complement Drug Players in 2021
Table 9. World Complement Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Complement Drug Company Evaluation Quadrant
Table 11. Head Office of Key Complement Drug Player
Table 12. Complement Drug Market: Company Product Type Footprint
Table 13. Complement Drug Market: Company Product Application Footprint
Table 14. Complement Drug Mergers & Acquisitions Activity
Table 15. United States VS China Complement Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Complement Drug in United States, Headquarters (States, Country)
Table 17. United States Complement Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Complement Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Complement Drug in China, Company Headquarters (Province, Country)
Table 20. China Complement Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Complement Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Complement Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Complement Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Complement Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Complement Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Complement Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World Complement Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World Complement Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Complement Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World Complement Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 32. Novartis AG Major Business
Table 33. Novartis AG Complement Drug Product and Services
Table 34. Novartis AG Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Novartis AG Recent Developments/Updates
Table 36. Novartis AG Competitive Strengths & Weaknesses
Table 37. Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. Alexion Pharmaceuticals Major Business
Table 39. Alexion Pharmaceuticals Complement Drug Product and Services
Table 40. Alexion Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Alexion Pharmaceuticals Recent Developments/Updates
Table 42. Alexion Pharmaceuticals Competitive Strengths & Weaknesses
Table 43. ChemoCentryx Basic Information, Manufacturing Base and Competitors
Table 44. ChemoCentryx Major Business
Table 45. ChemoCentryx Complement Drug Product and Services
Table 46. ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. ChemoCentryx Recent Developments/Updates
Table 48. ChemoCentryx Competitive Strengths & Weaknesses
Table 49. Roche Basic Information, Manufacturing Base and Competitors
Table 50. Roche Major Business
Table 51. Roche Complement Drug Product and Services
Table 52. Roche Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Roche Recent Developments/Updates
Table 54. Roche Competitive Strengths & Weaknesses
Table 55. Apellis Basic Information, Manufacturing Base and Competitors
Table 56. Apellis Major Business
Table 57. Apellis Complement Drug Product and Services
Table 58. Apellis Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Apellis Recent Developments/Updates
Table 60. Apellis Competitive Strengths & Weaknesses
Table 61. Regeneron Basic Information, Manufacturing Base and Competitors
Table 62. Regeneron Major Business
Table 63. Regeneron Complement Drug Product and Services
Table 64. Regeneron Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Regeneron Recent Developments/Updates
Table 66. Regeneron Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Complement Drug Product and Services
Table 70. Amgen Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Alnylam Basic Information, Manufacturing Base and Competitors
Table 74. Alnylam Major Business
Table 75. Alnylam Complement Drug Product and Services
Table 76. Alnylam Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Alnylam Recent Developments/Updates
Table 78. Alnylam Competitive Strengths & Weaknesses
Table 79. UCB Basic Information, Manufacturing Base and Competitors
Table 80. UCB Major Business
Table 81. UCB Complement Drug Product and Services
Table 82. UCB Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. UCB Recent Developments/Updates
Table 84. UCB Competitive Strengths & Weaknesses
Table 85. InflaRx Basic Information, Manufacturing Base and Competitors
Table 86. InflaRx Major Business
Table 87. InflaRx Complement Drug Product and Services
Table 88. InflaRx Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. InflaRx Recent Developments/Updates
Table 90. InflaRx Competitive Strengths & Weaknesses
Table 91. ChemoCentryx Basic Information, Manufacturing Base and Competitors
Table 92. ChemoCentryx Major Business
Table 93. ChemoCentryx Complement Drug Product and Services
Table 94. ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. ChemoCentryx Recent Developments/Updates
Table 96. ChemoCentryx Competitive Strengths & Weaknesses
Table 97. Innate Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Innate Pharma Major Business
Table 99. Innate Pharma Complement Drug Product and Services
Table 100. Innate Pharma Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Innate Pharma Recent Developments/Updates
Table 102. Innate Pharma Competitive Strengths & Weaknesses
Table 103. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Ionis Pharmaceuticals Major Business
Table 105. Ionis Pharmaceuticals Complement Drug Product and Services
Table 106. Ionis Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Ionis Pharmaceuticals Recent Developments/Updates
Table 108. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Avant Immunotherapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Avant Immunotherapeutics Major Business
Table 111. Avant Immunotherapeutics Complement Drug Product and Services
Table 112. Avant Immunotherapeutics Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Avant Immunotherapeutics Recent Developments/Updates
Table 114. Avant Immunotherapeutics Competitive Strengths & Weaknesses
Table 115. Pfizer Basic Information, Manufacturing Base and Competitors
Table 116. Pfizer Major Business
Table 117. Pfizer Complement Drug Product and Services
Table 118. Pfizer Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Pfizer Recent Developments/Updates
Table 120. Pfizer Competitive Strengths & Weaknesses
Table 121. Sanofi Basic Information, Manufacturing Base and Competitors
Table 122. Sanofi Major Business
Table 123. Sanofi Complement Drug Product and Services
Table 124. Sanofi Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Sanofi Recent Developments/Updates
Table 126. Sanofi Competitive Strengths & Weaknesses
Table 127. Omeros Basic Information, Manufacturing Base and Competitors
Table 128. Omeros Major Business
Table 129. Omeros Complement Drug Product and Services
Table 130. Omeros Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Omeros Recent Developments/Updates
Table 132. Omeros Competitive Strengths & Weaknesses
Table 133. GenMab Basic Information, Manufacturing Base and Competitors
Table 134. GenMab Major Business
Table 135. GenMab Complement Drug Product and Services
Table 136. GenMab Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. GenMab Recent Developments/Updates
Table 138. GenMab Competitive Strengths & Weaknesses
Table 139. Akari Therapeutics Basic Information, Manufacturing Base and Competitors
Table 140. Akari Therapeutics Major Business
Table 141. Akari Therapeutics Complement Drug Product and Services
Table 142. Akari Therapeutics Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Akari Therapeutics Recent Developments/Updates
Table 144. AbbVie Basic Information, Manufacturing Base and Competitors
Table 145. AbbVie Major Business
Table 146. AbbVie Complement Drug Product and Services
Table 147. AbbVie Complement Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 148. Complement Drug Raw Material
Table 149. Key Manufacturers of Complement Drug Raw Materials
Table 150. Complement Drug Typical Distributors
Table 151. Complement Drug Typical Customers
LIST OF FIGURES
Figure 1. Complement Drug Picture
Figure 2. World Complement Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Complement Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World Complement Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States Complement Drug Market Size (2017-2028) & (USD Million)
Figure 6. China Complement Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe Complement Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan Complement Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Complement Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Complement Drug Market Size (2017-2028) & (USD Million)
Figure 11. India Complement Drug Market Size (2017-2028) & (USD Million)
Figure 12. Complement Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Complement Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Complement Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Complement Drug Markets in 2021
Figure 17. United States VS China: Complement Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Complement Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Complement Drug Market Size Market Share by Type in 2021
Figure 20. Peptides
Figure 21. Antibodies
Figure 22. Others
Figure 23. World Complement Drug Market Size Market Share by Type (2017-2028)
Figure 24. World Complement Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Complement Drug Market Size Market Share by Application in 2021
Figure 26. Blood Disease
Figure 27. Kidney Disease
Figure 28. Others
Figure 29. World Complement Drug Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of Complement Drug in 2021
Figure 31. Manufacturing Process Analysis of Complement Drug
Figure 32. Complement Drug Industrial Chain
Figure 33. Distribution Channel Breakdown for Complement Drug Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source
Figure 1. Complement Drug Picture
Figure 2. World Complement Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Complement Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World Complement Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States Complement Drug Market Size (2017-2028) & (USD Million)
Figure 6. China Complement Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe Complement Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan Complement Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Complement Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Complement Drug Market Size (2017-2028) & (USD Million)
Figure 11. India Complement Drug Market Size (2017-2028) & (USD Million)
Figure 12. Complement Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Complement Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Complement Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Complement Drug Markets in 2021
Figure 17. United States VS China: Complement Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Complement Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Complement Drug Market Size Market Share by Type in 2021
Figure 20. Peptides
Figure 21. Antibodies
Figure 22. Others
Figure 23. World Complement Drug Market Size Market Share by Type (2017-2028)
Figure 24. World Complement Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Complement Drug Market Size Market Share by Application in 2021
Figure 26. Blood Disease
Figure 27. Kidney Disease
Figure 28. Others
Figure 29. World Complement Drug Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of Complement Drug in 2021
Figure 31. Manufacturing Process Analysis of Complement Drug
Figure 32. Complement Drug Industrial Chain
Figure 33. Distribution Channel Breakdown for Complement Drug Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source
